Slices from fresh human tumor specimens were incubated in presence of radioactive tracers and a spectrum of anticancer drugs. The drug effects were estimated from the changed rates of tracer incorporation into DNA, RNA, and protein. In a group of some 40 tumors analyzed the response of each tumor was highly individualistic although the observed effects were consistent with the known modes of action of respective drugs. Nevertheless, they could be classified broadly as: 1) tumors resistant to all drugs, 2) tumors sensitive to most drugs and 3) tumors selectively sensitive to one or few drugs and resistant against others. Case histories are given, which demonstrate the generally good correlation between in vitro and in vivo tumor sensitivities.